Drugs / Sheng Bai oral liquid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03413358 | Jan 2018 → Oct 2019 | non-small cell lung carcinoma | BeiJing Yijiayi Medicine Techonoloy Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sheng Bai oral liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03413358 ↗ |
| Route | Oral | “oral use” NCT03413358 ↗ |